Delayed return of gastrointestinal function after hepatectomy in an ERAS program: incidence and risk factors.


Journal

HPB : the official journal of the International Hepato Pancreato Biliary Association
ISSN: 1477-2574
Titre abrégé: HPB (Oxford)
Pays: England
ID NLM: 100900921

Informations de publication

Date de publication:
09 2022
Historique:
received: 15 12 2021
revised: 17 02 2022
accepted: 29 03 2022
pubmed: 29 4 2022
medline: 28 9 2022
entrez: 28 4 2022
Statut: ppublish

Résumé

Delayed return of gastrointestinal function (DGIF) after hepatectomy can involve increased morbidity and prolonged hospital stay. Yet, data on incidence and risks factors are lacking. All consecutive patients who underwent hepatectomy between June 2018 and December 2020 were included. All patients were included in an enhanced recovery after surgery (ERAS) program. DGIF was defined by the need for nasogastric tube (NGT) insertion after surgery. DGIF risk factors were identified. Overall, 206 patients underwent hepatectomy. DGIF occurred in 41 patients (19.9%) after a median time of 2 days (range, 1-14). Among them, 6 patients (14.6%) developed aspiration pneumonia, of which one required ICU for mechanical ventilation. DGIF developed along with an intraabdominal complication in 7 patients (biliary fistula, n = 5; anastomotic fistula, n = 1; adhesive small bowel obstruction, n = 1). DGIF was associated with significantly increased severe morbidity rate (p = 0.001), prolonged time to normal food intake (p < 0.001) and hospital stay (p < 0.001) and significantly decreased overall compliance rate (p = 0.001). Independent risk factors of DGIF were age (p < 0.001), vascular reconstruction (p = 0.007), anaesthetic induction using volatiles (p = 0.003) and epidural analgesia (p = 0.004). Using these 4 variables, a simple DGIF risk score has been developed allowing patient stratification in low-, intermediate- and high-risk groups. DGIF after hepatectomy was frequently observed and significantly impacted postoperative outcomes. Identifying risk factors remains critical for preventing its occurrence.

Sections du résumé

BACKGROUND
Delayed return of gastrointestinal function (DGIF) after hepatectomy can involve increased morbidity and prolonged hospital stay. Yet, data on incidence and risks factors are lacking.
METHODS
All consecutive patients who underwent hepatectomy between June 2018 and December 2020 were included. All patients were included in an enhanced recovery after surgery (ERAS) program. DGIF was defined by the need for nasogastric tube (NGT) insertion after surgery. DGIF risk factors were identified.
RESULTS
Overall, 206 patients underwent hepatectomy. DGIF occurred in 41 patients (19.9%) after a median time of 2 days (range, 1-14). Among them, 6 patients (14.6%) developed aspiration pneumonia, of which one required ICU for mechanical ventilation. DGIF developed along with an intraabdominal complication in 7 patients (biliary fistula, n = 5; anastomotic fistula, n = 1; adhesive small bowel obstruction, n = 1). DGIF was associated with significantly increased severe morbidity rate (p = 0.001), prolonged time to normal food intake (p < 0.001) and hospital stay (p < 0.001) and significantly decreased overall compliance rate (p = 0.001). Independent risk factors of DGIF were age (p < 0.001), vascular reconstruction (p = 0.007), anaesthetic induction using volatiles (p = 0.003) and epidural analgesia (p = 0.004). Using these 4 variables, a simple DGIF risk score has been developed allowing patient stratification in low-, intermediate- and high-risk groups.
CONCLUSION
DGIF after hepatectomy was frequently observed and significantly impacted postoperative outcomes. Identifying risk factors remains critical for preventing its occurrence.

Identifiants

pubmed: 35484074
pii: S1365-182X(22)00091-0
doi: 10.1016/j.hpb.2022.03.014
pii:
doi:

Substances chimiques

Anesthetics 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1560-1568

Informations de copyright

Copyright © 2022 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.

Auteurs

Sara Arfa (S)

Department of Digestive Surgical Oncology -Liver Transplantation Unit, CHU Besançon, France.

Célia Turco (C)

Department of Digestive Surgical Oncology -Liver Transplantation Unit, CHU Besançon, France.

Zaher Lakkis (Z)

Department of Digestive Surgical Oncology -Liver Transplantation Unit, CHU Besançon, France.

Sandrine Bourgeois (S)

Department of Digestive Surgical Oncology -Liver Transplantation Unit, CHU Besançon, France.

Isabelle Fouet (I)

Department of Anesthesiology and Intensive Care Medicine. CHU Besançon, France.

Philippe Evrard (P)

Department of Digestive Surgical Oncology -Liver Transplantation Unit, CHU Besançon, France.

Elise Sennegon (E)

Department of Digestive Surgical Oncology -Liver Transplantation Unit, CHU Besançon, France.

Alexandra Roucoux (A)

Department of Digestive Surgical Oncology -Liver Transplantation Unit, CHU Besançon, France.

Brice Paquette (B)

Department of Digestive Surgical Oncology -Liver Transplantation Unit, CHU Besançon, France.

Bénédicte Devaux (B)

Department of Anesthesiology and Intensive Care Medicine. CHU Besançon, France.

Anne Rietsch-Koenig (A)

Department of Anesthesiology and Intensive Care Medicine. CHU Besançon, France.

Bruno Heyd (B)

Department of Digestive Surgical Oncology -Liver Transplantation Unit, CHU Besançon, France.

Alexandre Doussot (A)

Department of Digestive Surgical Oncology -Liver Transplantation Unit, CHU Besançon, France. Electronic address: adoussot@chu-besancon.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH